Mirtazapine and Immunodeficiency disorders - a phase IV clinical study of FDA data

Summary:

Immunodeficiency disorders is reported as a side effect among people who take Mirtazapine (mirtazapine), especially for people who are female, 30-39 old, also take Magnesium, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Immunodeficiency disorders when taking Mirtazapine. It is created by eHealthMe based on reports of 79,492 people who have side effects when taking Mirtazapine from the FDA, and is updated regularly.

What is Mirtazapine?

Mirtazapine has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 82,120 Mirtazapine users. Check the latest studies of Mirtazapine.

What is Immunodeficiency disorders?

Immunodeficiency disorders is found to be associated with 709 drugs and 941 conditions by eHealthMe. Check the latest studies of Immunodeficiency disorders.

On Jul, 12, 2026

79,492 people reported to have side effects when taking Mirtazapine.
Among them, 49 people (0.06%) have Immunodeficiency disorders.

Could Mirtazapine cause Immunodeficiency disorders?

Among these 49 people:

What is the gender of people who have Immunodeficiency disorders when taking Mirtazapine? *

female: 69.57 %
male: 30.43 %

What is the age of people who have Immunodeficiency disorders when taking Mirtazapine? *

What are other drugs people take besides Mirtazapine? *

What are other side effects people have besides Immunodeficiency disorders? *

Fatigue (feeling of tiredness): 21 people, 42.86%
The Flu (the flu is caused by an influenza virus): 18 people, 36.73%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 17 people, 34.69%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 16 people, 32.65%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 16 people, 32.65%
Food Craving: 16 people, 32.65%
Fall: 16 people, 32.65%
Oedema Peripheral (superficial swelling): 16 people, 32.65%
Drowsiness: 16 people, 32.65%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 16 people, 32.65%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 16 people, 32.65%
Neuralgia (pain in one or more nerves): 14 people, 28.57%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 14.29%
High Blood Pressure: 6 people, 12.24%
Psoriasis (immune-mediated disease that affects the skin): 4 people, 8.16%
Pain: 4 people, 8.16%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 6.12%
Nausea (feeling of having an urge to vomit): 3 people, 6.12%
Flatulence (flatus expelled through the anus): 3 people, 6.12%
Oropharyngeal Pain: 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Mirtazapine and have Immunodeficiency disorders?

- Check whether Immunodeficiency disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirtazapine:

Mirtazapine (82,120 reports)

Browse all side effects of Mirtazapine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Immunodeficiency disorders:

Immunodeficiency disorders (709 drugs)

Browse all the conditions that are associated with Immunodeficiency disorders:

Immunodeficiency disorders (941 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Mirtazapine) and Mirtazapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.